Apr 30, 2010
2nd Circuit Affirms Decision Favoring Drug Companies on ‘Pay to Delay’ Settlements
A federal appeals court on Thursday upheld summary judgment granted to drug companies sued for violating antitrust laws through so-called “pay-for-delay” patent settlements. But the case is far from over. The 2nd Circuit affirmed the ruling only because it was bound by its own precedent on the issue, and said it was unable to address policy arguments